Evkeeza OverviewEvinacumab, sold under the brand name Evkeeza, is a monoclonal antibody medication for the treatment of homozygous familial hypercholesterolemia (HoFH). Common side effects include nasopharyngitis (cold), influenza-like illness, dizziness, rhinorrhea (runny nose), and nausea. Serious hypersensitivity (allergic) reactions have occurred in the Evkeeza clinical trials. Evinacumab binds to the angiopoietin-like protein 3 (ANGPTL3).[...
Read more Evkeeza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Evinacumab
Recent Evkeeza Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution: 1200mg/8ml, 345mg/2.3ml
NDC Database Records for Evkeeza: (2 results)Sorted by National Drug Code
- 61755-010 Evkeeza 150 mg/ml Intravenous Injection, Solution, Concentrate by Regeneron Pharmaceuticals, Inc.
- 61755-013 Evkeeza 150 mg/ml Intravenous Injection, Solution, Concentrate by Regeneron Pharmaceuticals, Inc.